Sign in
4

Changes in Ownership

Bicara Therapeutics Inc. Filed Acc 0002023658-25-000085

Chief Legal Officer sold 15,829 shares at $10.43 ($165,096)

  • Chief Legal Officer acquired 15,829 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Meisner Lara Chief Legal Officer 2025-06-16 Option exercise 10b5-1 +15,829 $5.45 $86,268 15,829 D: show line 1 in the form
Meisner Lara Chief Legal Officer 2025-06-16 Sale 10b5-1 −15,829 $10.43 $165,096 0 D: show line 2 in the form
Open-market sales · 15,829 sh · avg $10.43 · $165,096

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Meisner Lara Chief Legal Officer 2025-06-16 Option exercise · Stock Option (Right to Buy) 10b5-1 −6,085 60,854 D: show line 3 in the form
Meisner Lara Chief Legal Officer 2025-06-16 Option exercise · Stock Option (Right to Buy) 10b5-1 −9,744 97,443 D: show line 4 in the form
Loading xslF345X05/wk-form4_1750281133.xml…